Not applicableStudy completedNCT02269982What this trial is testingProspective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studYWho this might be right forProstate Cancer Duke University 120
Early research (Phase 1)Looking for participantsNCT07277270What this trial is testingGSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 83
Testing effectiveness (Phase 2)Looking for participantsNCT06970119What this trial is testingA Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate CancerWho this might be right forProstate Cancer Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Testing effectiveness (Phase 2)UnknownNCT01487902What this trial is testingThe Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic CancerWho this might be right forCastration-resistant Prostate Cancer Asan Medical Center 90
Not applicableWithdrawnNCT01692483What this trial is testingPost-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate CancerWho this might be right forProstate Neoplasms Janssen Pharmaceutica
Early research (Phase 1)Study completedNCT00326586What this trial is testingA Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Bristol-Myers Squibb 54
Not applicableStudy completedNCT02588001What this trial is testingJapanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - EnzalutamideWho this might be right forProstate Cancer Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 60
Testing effectiveness (Phase 2)Study completedNCT03888612What this trial is testingTrial of ARV-110 in Patients With Metastatic Castration Resistant Prostate CancerWho this might be right forProstate Cancer Metastatic Arvinas Inc. 248
Large-scale testing (Phase 3)WithdrawnNCT02053311What this trial is testingOrteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal AgentsWho this might be right forProstate Cancer Swiss Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT04631601What this trial is testingSafety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)Who this might be right forMetastatic Castration-resistant Prostate Cancer Amgen 55
Testing effectiveness (Phase 2)Ended earlyNCT03577028What this trial is testingStudy of HPN424 in Patients With Advanced Prostate CancerWho this might be right forAdvanced Prostate Cancer Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 104
Early research (Phase 1)Study completedNCT01911728What this trial is testingDrug-drug Interaction Study With MDV3100 and a Cocktail of SubstratesWho this might be right forPharmacokinetics of MDV3100Castration Resistant Prostate Cancer (CRPC) Astellas Pharma Europe B.V. 14
Testing effectiveness (Phase 2)Looking for participantsNCT05534646What this trial is testingStudy of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate CancerWho this might be right forCastration-resistant Prostate Cancer Edwin Posadas, MD 100
Very early researchUnknownNCT04225910What this trial is testingClinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 20
Early research (Phase 1)Study completedNCT02655822What this trial is testingPhase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced CancersWho this might be right forRenal Cell CancerMetastatic Castration Resistant Prostate Cancer Corvus Pharmaceuticals, Inc. 502
Early research (Phase 1)Study completedNCT01347788What this trial is testingCabozantinib (XL184) in Men With Castrate-Resistant Prostate CancerWho this might be right forProstate Adenocarcinoma Massachusetts General Hospital 34
Not applicableStudy completedNCT03658486What this trial is testingExercise for Advanced Prostate Cancer: a Multicomponent Feasibility TrialWho this might be right forProstate Cancer MetastaticCastration-resistant Prostate Cancer Queen's University, Belfast 30
Testing effectiveness (Phase 2)Looking for participantsNCT06100705What this trial is testingSipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPCWho this might be right forMetastatic Castration-resistant Prostate Cancer Yale University 26
Testing effectiveness (Phase 2)Looking for participantsNCT06267729What this trial is testingStudy of AZD0754 in Participants With Metastatic Prostate CancerWho this might be right forMetastatic Prostate Cancer AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT05655715What this trial is testingCheckpoint Inhibitors and SBRT for MCRPCWho this might be right forProstate Cancer MetastaticCastrate Resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer+1 more Herlev and Gentofte Hospital 90